je.st
news
Home
› Molecular Devices Partners With Roche To Develop Custom Ruthenium Nano-TRF Detection Platform
Molecular Devices Partners With Roche To Develop Custom Ruthenium Nano-TRF Detection Platform
2014-11-05 07:07:55| drugdiscoveryonline Home Page
The custom technologies arm of Molecular Devices, a leader in bioanalytical systems for drug discovery, life science research, and bioassay development, has partnered with the Discovery Technologies team at the Roche Innovation Center Basel of Pharma Research and Early Development (pRED) to develop a high-throughput detection system for drug discovery screens employing Roche's proprietary Ruthenium-based nanosecond time resolved fluorescence (Nano-TRF®) assays
Tags: partners
develop
custom
devices
Category:Biotechnology and Pharmaceuticals